147 related articles for article (PubMed ID: 37827426)
1. Resolving heterogeneity in Alzheimer's disease based on individualized structural covariance network.
Zheng C; Zhao W; Yang Z; Tang D; Feng M; Guo S;
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110873. PubMed ID: 37827426
[TBL] [Abstract][Full Text] [Related]
2. Resolving heterogeneity in depression using individualized structural covariance network analysis.
Han S; Zheng R; Li S; Zhou B; Jiang Y; Fang K; Wei Y; Pang J; Li H; Zhang Y; Chen Y; Cheng J
Psychol Med; 2023 Aug; 53(11):5312-5321. PubMed ID: 35959558
[TBL] [Abstract][Full Text] [Related]
3. Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups.
Groot C; Grothe MJ; Mukherjee S; Jelistratova I; Jansen I; van Loenhoud AC; Risacher SL; Saykin AJ; Mac Donald CL; Mez J; Trittschuh EH; Gryglewski G; Lanzenberger R; Pijnenburg YAL; Barkhof F; Scheltens P; van der Flier WM; Crane PK; Ossenkoppele R
Neuroimage Clin; 2021; 30():102660. PubMed ID: 33895633
[TBL] [Abstract][Full Text] [Related]
4. Resolving heterogeneity in obsessive-compulsive disorder through individualized differential structural covariance network analysis.
Han S; Xu Y; Guo HR; Fang K; Wei Y; Liu L; Cheng J; Zhang Y; Cheng J
Cereb Cortex; 2023 Feb; 33(5):1659-1668. PubMed ID: 35470393
[TBL] [Abstract][Full Text] [Related]
5. HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework.
Varol E; Sotiras A; Davatzikos C;
Neuroimage; 2017 Jan; 145(Pt B):346-364. PubMed ID: 26923371
[TBL] [Abstract][Full Text] [Related]
6. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
Ten Kate M; Dicks E; Visser PJ; van der Flier WM; Teunissen CE; Barkhof F; Scheltens P; Tijms BM;
Brain; 2018 Dec; 141(12):3443-3456. PubMed ID: 30351346
[TBL] [Abstract][Full Text] [Related]
7. Altered Functional Network Affects Amyloid and Structural Covariance in Alzheimer's Disease.
Chang YT; Huang CW; Chang WN; Lee JJ; Chang CC
Biomed Res Int; 2018; 2018():8565620. PubMed ID: 30627575
[TBL] [Abstract][Full Text] [Related]
8. Exploring the heterogeneity of brain structure in autism spectrum disorder based on individual structural covariance network.
Guo X; Zhang X; Chen H; Zhai G; Cao Y; Zhang T; Gao L
Cereb Cortex; 2023 Jun; 33(12):7311-7321. PubMed ID: 36813465
[TBL] [Abstract][Full Text] [Related]
9. Profiling heterogeneity of Alzheimer's disease using white-matter impairment factors.
Sui X; Rajapakse JC;
Neuroimage Clin; 2018; 20():1222-1232. PubMed ID: 30412925
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
[TBL] [Abstract][Full Text] [Related]
11. Morphological and Structural Network Analysis of Sporadic Alzheimer's Disease Brains Based on the APOE4 Gene.
Dai WZ; Liu L; Zhu MZ; Lu J; Ni JM; Li R; Ma T; Zhu XC
J Alzheimers Dis; 2023; 91(3):1035-1048. PubMed ID: 36530087
[TBL] [Abstract][Full Text] [Related]
12. Causal structural covariance network revealing atrophy progression in Alzheimer's disease continuum.
Qing Z; Chen F; Lu J; Lv P; Li W; Liang X; Wang M; Wang Z; Zhang X; Zhang B;
Hum Brain Mapp; 2021 Aug; 42(12):3950-3962. PubMed ID: 33978292
[TBL] [Abstract][Full Text] [Related]
13. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
[TBL] [Abstract][Full Text] [Related]
14. Gray matter structural covariance networks changes along the Alzheimer's disease continuum.
Li K; Luo X; Zeng Q; Huang P; Shen Z; Xu X; Xu J; Wang C; Zhou J; Zhang M;
Neuroimage Clin; 2019; 23():101828. PubMed ID: 31029051
[TBL] [Abstract][Full Text] [Related]
15. Differences in structural covariance brain networks between behavioral variant frontotemporal dementia and Alzheimer's disease.
Hafkemeijer A; Möller C; Dopper EG; Jiskoot LC; van den Berg-Huysmans AA; van Swieten JC; van der Flier WM; Vrenken H; Pijnenburg YA; Barkhof F; Scheltens P; van der Grond J; Rombouts SA
Hum Brain Mapp; 2016 Mar; 37(3):978-88. PubMed ID: 26660857
[TBL] [Abstract][Full Text] [Related]
16. Exploring morphological similarity and randomness in Alzheimer's disease using adjacent grey matter voxel-based structural analysis.
Chen TY; Zhu JD; Tsai SJ; Yang AC
Alzheimers Res Ther; 2024 Apr; 16(1):88. PubMed ID: 38654366
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
Tijms BM; Gobom J; Reus L; Jansen I; Hong S; Dobricic V; Kilpert F; Ten Kate M; Barkhof F; Tsolaki M; Verhey FRJ; Popp J; Martinez-Lage P; Vandenberghe R; Lleó A; Molinuevo JL; Engelborghs S; Bertram L; Lovestone S; Streffer J; Vos S; Bos I; ; Blennow K; Scheltens P; Teunissen CE; Zetterberg H; Visser PJ
Brain; 2020 Dec; 143(12):3776-3792. PubMed ID: 33439986
[TBL] [Abstract][Full Text] [Related]
20. Altered Gray Matter Structural Covariance Networks in Early Stages of Alzheimer's Disease.
Montembeault M; Rouleau I; Provost JS; Brambati SM;
Cereb Cortex; 2016 Jun; 26(6):2650-62. PubMed ID: 25994962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
